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Results: Coculture of the U937 cells with synovial ﬁbroblasts resulted in
differentiation of U937 into monocytes, as evidenced by FACS indicating
that they were CD14+. Over 7 days, the cytokine and chemokine levels
in the media of these cocultured cells with cartilage explants approached
levels similar to those reported for OA synovial ﬂuid, including low levels
of Il-1b and TNFa. GAG release was observed in co-cultures stimulated
with Il-1b, uPA, or Fn-f, with the most severe effects in the Il-1b-treated
group (Figure). However, the concentration of Il-1b used in the control
samples, typical of concentrations used by others for release of GAGs
from cartilage disks in vitro, is far greater than the concentration reported
in OA synovial ﬂuid. Pretreatment with Il-1ra was able to inhibit the loss of
GAG from the cartilage in the Il-1b stimulated samples, but did not block
Fn-f-stimulated GAG release in the co-culture system, and had a small
effect on uPA stimulated GAG release.
Conclusions: An in vitro model of cartilage degradation has been devel-
oped utilizing a co-culture of human synovial ﬁbroblasts with differentiated
U937 cells, in the presence of bovine cartilage explants. The interaction
of these cell types generated a cytokine proﬁle similar to OA synovial
ﬂuid, and stimulation of this system with uPA or Fn-f led to cartilage
degradation (GAG loss). Our ongoing work will continue to explore the
roles of various cytokines and the molecular mechanisms through which
they inﬂuence cartilage degeneration in this in vitro joint model system,
and their potential relation to OA disease progression.
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444 OSTEOARTHRITIS AND AGE RELATED CHANGES IN
AGGRECAN AND COLAGEN IN HUMAN HIP CARTILAGE
S. Hosseininia, L. Lindberg, L. Dahlberg. Lund University, Malmo¨,
SWEDEN
Purpose: To conﬁrm that previously reported changes in collagen and
GAG content from knee OA cartialge also occur in hip OA and that
these changes are different from those in reference cartilages. We also
examined the relationships between total collagen, % denatured collagen
and GAG content and with age.
Methods: 18 OA (aged 45 to 81, 11 women) and 26 reference (aged 55
to 99 years, 20 women) femoral heads were collected at hip replacement
surgery, due to OA or femoral neck fracture. OA cartilages were taken
from sites where it was possible to sample full-depth cartilages whereas
reference cartilages were taken from the superior most loaded areas.
Cartilages from the same site were examined for routine histology and
immunohistochemistry. Each sample was divided into two parts that were
either, digested with 1mg/ml a-Chymotrypsin in 50mM tris containing
the proteinase inhibitors to extract denatured collagen, or with papain
at 60C for 18 h (1−2ml of papain/10mg wet weight tissue) in 0.1M tris-
HCl, pH 7.2, containing 0.01M disodium EDTA and 0.005 cysteine-HCl
to enable GAG analysis. The Chymotrypsin supernatants (containing
cleaved collagen) and residues (containing intact collagen) were hydrol-
ysed in 12N and 6N HCl, respectively, at 110ºC overnight and then
dried. Subsequently the samples were dissolved in 500 ml of distilled
water and clariﬁed using an equal amount of charcoal and AG-1 X8
anoin exchange resin. The amount of hydroxyproline (Hyp. mg/mg wet
weight) was measured colorimetrically at 550 nm. The values from the
assay were compared to those from a standard curve prepared with
L-4-Hydroxyproline. Amounts of hydroxyproline were expressed either
as total collagen or % degradation. The papain-digested samples were
assayed for GAG by a commercially available kit using dye-precipitation
of sulphated GAGs with Alcian blue (www.wieslab.com).
Results: The reference group was older than the OA group (p< 0.001).
Collagen content was 23% lower in OA than reference cartilage
(p = 0.002). % Denatured collagen was 2.5 times higher in OA than that
of reference cartilages (p = 0.001).
% Denaturation was inversely related to collagen content in OA cartilage
(r = −0.78, p = 0.000) but not in the reference cartilage (p = 0.5).
GAG content was similar in reference and OA cartilages. GAG content
was inversely related to % denatured collagen in OA and reference sam-
ples; lower GAG was present in samples with more denatured collagen.
Amounts of collagen and GAG and % denatured collagen were not
related to patients’ age. The Mankin and immunohistochemistry grades,
higher in OA than in reference samples (p< 0.001), were not related to
% denaturation, collagen or GAG content.
Conclusions: The present study provides new perspectives of the re-
lationships between the two main molecules, collagen and aggrecan, in
OA and reference articular cartilage. Similar collagen damage in hip OA
cartilage as previously shown in knee OA cartilage suggest similar OA
degradative mechanisms of collagen in different joints. With respect to
age, our study shows similarities between OA and reference cartilage.
The lack of relationships between molecule contents and age may sug-
gest that subjects age is not related to disease activity or suseptibility.
Rather we believe that exposure time to a risk factor is of importance.
The increased degree of denatured collagen and the inverse relationship
between % denatured collagen and collagen content in OA compared to
reference cartilage indicates mechanisms of progressiveness in disease
that are not activated in normal ageing. Therapeutic interventions in
progressive hip and knee OA may include means to control cartilage
collagen content using inhibitors that decrease collagen degradation as
well as treatments that increase cartilage GAG content in order to improve
cartilage quality.
445 P38 MAPK IS AN ESSENTIAL UPSTREAM SIGNALLING
PATHWAY IN PROTEOLYTIC CARTILAGE DEGRADATION
B-C. Sondergaard, N. Schultz, M.A. Karsdal. Nordic Bioscience, Herlev,
DENMARK
Purpose: Matrix Metalloproteases (MMP) and aggrecanases are essen-
tial players in cartilage degradation. However, the signaling pathways
involved that results in MMP and aggrecanase synthesis and activation
are not well understood. We investigated whether the p38 MAPK was
involved in processes leading to collagen type II degradation in catabolic
stimulated articular cartilage.
Methods: Bovine articular cartilage explants were isolated from stiﬂe
joints from slaughtered cows 1.5−2 years of age. The explants were cul-
tured serum-free in Dulbecco’s Modiﬁed Eagle’s Medium in the presence
of 10 ng/ml Oncostatin M (OSM) and 20 ng/ml Tumor Necrosis Factor-a
(TNF) with or without the speciﬁc inhibitors of p38 MAPK SB-203580
or SB-202190, respectively, in doses of 0.1, 1 or 10 mM for 21 days
with change of conditioned medium every 2−3 day. Cartilage explants
cultured in medium alone and metabolically inactivated explants were
used as control. Cell viability was followed by the Alamar blue colorimetric
assay. Total cartilage proteoglycans were isolated from the cultured
cartilage explants after the culture period by 4M GuHCl extraction for
48 h. Collagen type II degradation was analyzed by the CTX-II assay
and by hydroxyproline quantiﬁcation. MMP activity was assessed in the
conditioned medium using the Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-
NH2 MMP substrate with a quencher and a highly ﬂuorescent end, and
the cleavage was followed by quantiﬁcation of the ﬂuorescence.
Results: Stimulation of cartilage degradation by OSM+TNF resulted in
a 100-fold induction of CTX-II release (p< 0.01), compared to vehicle
treated and metabolic inactive controls. The total levels of proteoglycan
in the explants decreased by 50%, p< 0.0001 in the OSM + TNF treated
cartilage compared to vehicle control, but the p38 inhibitor SB-203580
was able to retain the levels of proteoglycans by 35%, p< 0.01, compared
to vehicle control. Exposure of the articular cartilage explants to OSM +
TNF, and the speciﬁc p38 MAPK inhibitors SB-203580 or SB-202190,
resulted in a dose-dependent complete abrogation of MMP mediated
collagen type II degradation (CTX-II). This was in alignment to the quantiﬁ-
cation of hydroxyproline levels, (p< 0.01). In support, p38 MAPK inhibition
resulted in a dose-dependent abrogation of MMP activity measured by
the ﬂuorescence assay. In addition, no toxic effect was observed on cell
viability.
Conclusions: We found that the inhibition of p38 MAPK abrogated
proteolytic cartilage degradation by blocking MMP synthesis and activity.
These results suggest that pathways resulting in less p38 signaling may
be potential options for indirect modulation of MMP expression and
activity. This may be important for the discovery of new potential OA
treatments.
446 DETECTION OF THE EARLY CHANGE OF THE CARTILAGE
DEGENERATION WITH FTIR AND ULTRASOUND
EVALUATION
K. Nishitani1, M. Kobayashi1, K. Mori2, H. Kuroki1, T. Shirai1,
Y. Nakagawa1, T. Nakamura1. 1Kyoto University, Kyoto, JAPAN,
2Yamaguchi University, Ube, JAPAN
Purpose: Early diagnosis of osteoarthritis is important, although the
diagnostic method is not fully established yet. It is well known that
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collagen content decreases in late stage osteoarthritis. In early stage, it is
reported that anabolism of the collagen increases. The hypothesis of this
study is that the collagen content increases in the slightly degenerated
cartilage. In our group, material properties of the articular cartilage were
examined with ultrasound cartilage evaluation system. In this study,
Fourier Transform Infrared (FTIR) imaging was also used to evaluate the
collagen content of articular cartilage.
Methods: Fourier Transform Infrared spectrometer (FT-IR-460 PLUS:
JASCO: Tokyo) coupled to a microscope (Intron-IRT-30: JASCO: Tokyo)
was used to acquire data. Human articular cartilage was obtained at total
knee arthroplasty and was graded by ICRS grading. Then, the mechanical
properties of the cartilage were measured with our ultrasound cartilage
evaluating system with wavelet transform method. Three parameters were
used; signal intensity (index of the stiffness), signal duration (index of
roughness) and signal interval (index of thickness). Then frozen section
of 5mm was made for FTIR imaging. In FTIR imaging, the integrated area
under the protein amide I and II (1710–1570 cm−1) was used as collagen
content. For quantitative analysis, the cartilage of weight bearing area
of the lateral femoral condyle was selected to avoid the site dependent
variance. Sample number was 10 of Grade-0 (G0), 10 of G1, 6 of G2
and 0 of G3 from 10 patients. In statistical analysis, one-way ANOVA
was used and p< 0.05 was deﬁned to be signiﬁcant.
Results: In the mapping of collagen content with FTRI, in G0 cartilage,
collagen rich area existed in surface and deep layer. In G1 cartilage,
the collagen content of superﬁcial area decreased and the collagen
content in deep layer increased. In G3, collagen content decreased in
whole layer. In quantitative analysis, there was no difference in collagen
content between G0, G1 and G2 cartilage when whole layer of cartilage
was examined. In superﬁcial layer, collagen content decreased as ICRS
advanced (Figure A). Otherwise, in deep layer, the G1 cartilage had
signiﬁcantly richer collagen content than G0 or G2 cartilage (Figure B).
In ultrasound evaluation, signal intensity declined (Figure C) and signal
duration increased as ICRS grade advanced. There was signiﬁcant dif-
ference between G0 and G1 cartilage in these two parameters. Further
examination whether the signal intensity (index of the cartilage stiffness)
reﬂects the collagen content of the cartilage was performed. Signal
intensity had a signiﬁcant correlation with collagen content in superﬁcial
layer (R=0.80).
Conclusions: In this study, the change of the collagen content in G1
cartilage differs in superﬁcial layer and in deep layer. As a result of an
increase of anabolism, the collagen content of G1 cartilage increased in
deep layer. However, collagen content of superﬁcial layer decreased. We
think that catabolism occurs stronger than anabolism and the collagen
content decreases. Recently, the collagen content of the cartilage has
been measured non-invasively with such as MRI T2 mapping method.
These changes of the collagen content of G1 cartilage may become a
candidate for early diagnosis of the cartilage degeneration. Ultrasound is
also a non-invasive method and the change of the signal intensity can
be used to guess the collagen content of the superﬁcial layer of articular
cartilage.
447 MATRIX METALLOPROTEINASE (MMP)-12 REGULATES
MMP-9 EXPRESSION IN INTERLEUKIN-1b-TREATED
ARTICULAR CHONDROCYTES
H. Oh, M. Park, K. Oh, J. Jeon, J-S. Chun. Cell Dynamics Research
Center and Department of Life Science, Gwangju Institute Science and
Technology, Gwangju, REPUBLIC OF KOREA
Purpose: Limited information is currently available on the expression
levels and roles of matrix metalloproteinase (MMP)-12 in chondrocytes.
In this study, we characterize the expression mechanisms of MMP-12 and
its possible function in cartilage destruction.
Methods: The expression mechanisms of MMP-12 and MMP-9 were
determined using reverse transcriptase polymer chain reaction (RT-PCR),
quantitative real-time polymerase chain reaction (qRT-PCR), Western
blotting, reporter gene assay, and zymography in primary culture chon-
drocytes either treated with interleukin (IL)-1b or left untreated. The roles
of mitogen-activated protein (MAP) kinase subtypes were additionally
examined with speciﬁc inhibitors. The function of MMP-12 was assayed
in chondrocytes treated with the recombinant active protein.
Results: Il-1b induced the expression, secretion and activation of MMP-
12 in chondrocytes and cartilage explants via MAP kinase pathways.
Extracellular signal-regulated kinase and p38 kinase regulated MMP-12
expression, whereas c-jun N-terminal kinase modulated activation. MMP-
12 enhanced MMP-9 expression and secretion in the presence of Il-1b in
chondrocytes.
Conclusions: Il-1b in chondrocytes induces the expression and activation
of MMP-12, which, in turn, augments MMP-9 expression and secretion.
Our results support the possible involvement of MMP-12 in cartilage
destruction.
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448 RHEOLOGICAL PROPERTIES OF OSTEOARTHRITIC
SYNOVIAL FLUID BEFORE AND AFTER ADDITION OF
DIFFERENT HYALURONIC ACID FORMULATIONS
T. Conrozier1, P. Mathieu1, Y. Rozand2, E. Vignon1, M. Rinaudo3.
1Centre Hospitalier Lyon Sud, Pierre Be´nite, FRANCE, 2Centre de
Rhumatologie, Grenoble, FRANCE, 3Centre de Recherches sur les
Macromolecules Ve´ge´tales (CERMAV-CNRS), Grenoble, FRANCE
Purpose: To assess in vitro the effect of 2 formulations of viscosupple-
ment, linear and a cross-linked hyaluronic acid (HA) on the synovial ﬂuid
(SF) rheology.
Methods: SF were obtained by sterile aspiration of the affected joints
in 14 patients suffering from knee OA. SF samples were collected in
sterile tubes and stocked at 4ºC. SF were characterized by size exclusion
chromatography (SEC) and rheology. From SEC experiments it was
possible to determine the different parameters (concentrations, average
molecular weights of HA). Two viscosupplements (a cross-linked HA with
an apparent MW of 6mDa and a linear HA with an average MW of
1.1mDa) were then added to SF in a ratio 1/1 to test their effects on SF
behaviour. The rheological behaviour of SF and SF+HA was determined
using an AR 1000 rheometer.
Results: The concentration of HA varied from 0.2 to 2.5 g/L. In steady
state ﬂow the rheological behaviour of SF was non Newtonian. The
addition of linear HA modiﬁed only slightly the behaviour of SF. It espe-
cially increased viscosity at higher shear rate and decreased shear rate
dependence of the SF suggesteing the SF/exogenous HA interaction. On
the opposite, the addition of cross-linked HA gave a large non-Newtonian
